MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Quick Stats
May 14, 202656.9
AI Score
HOLD0.28
Volume Ratio
May 11, 2026
Next Earnings
15
+ve Days (30d)
14
-ve Days (30d)
MLTX Stock Summary
Last updated May 14, 2026
MLTX is currently trading at $18.445, positioned below its 200-day moving average of $23.11, suggesting bearish momentum. The stock has a 52-week range of $5.95 to $62.75.
Technical Analysis: The 50-day moving average stands at $17.49, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.491, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.163, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MLTX at 56.9/100 with a HOLD recommendation.
MLTX (MoonLake Immunotherapeutics Class A Ordinary Shares) Indicators
Last updated May 14, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 54.491 |
| CMF (20) | -0.163 |
| ROC (10) | 10.867 |
| ADX (14) | 22.171 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.186 |
| AROONOSC (14) | 57.143 |
| WILLAMS %R (14) | -56.914 |
| MFI (14) | 57.254 |
MLTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MLTX Price vs Max Options Open Interest
MLTX Max Change In Options Open Interest
MLTX Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLTX Daily Out of Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLTX Daily In the Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLTX Most Active Options by Volume(near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MoonLake Immunotherapeutics Class A Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MLTX Moving Averages Analysis
MoonLake Immunotherapeutics Class A Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on May 14, 2026
MLTX (MoonLake Immunotherapeutics Class A Ordinary Shares) Simple Moving Averages
Moving Averages are last updated May 14, 2026
| Days | MA |
|---|---|
| 10 | 17.71 |
| 20 | 17.4 |
| 30 | 17.61 |
| 50 | 17.49 |
| 100 | 16.64 |
| 200 | 23.11 |
MLTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.3 billion |
| Earnings/Share ($) | -3.88 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.8164 |
| EPS Estimate Next Year ($) | -3.6432 |
| WallStreet Target Price ($) | 26.7692 |
| Most Recent Quarter |
SLK, a small molecule NanoBody for inflammatory skin diseases, is expected to see strong price action with the upcoming Week 52 data release from VELA. The company is also set to expand its label to age 12 and over with the Vela Teen, followed by IZAR-1 and BLA submission by September. Analysts' price expectations for MLTX were sharply cut, leading to market hysteria and attacks by short sellers. Despite profit-taking by penny chasers, the Week 52 dataset is expected to bring positive news for MLTX investors. Focus on the science of SLK and ignore distractions, as the drug is predicted to bring life-changing wealth for investors. Retail investors own 7.53% of MLTX, and the stock is expected to rise in the next 30-60 days.
Updated 2026-05-11 12:00:01